title: Recurrent steroid-responsive cerebral vasogenic edema in status migrainosus and persistent aura.
abstract: BACKGROUND
  Status migrainosus (SM) and persistent aura (PA) without infarction are complications of migraine. Although several patients have been reported to have reversible brain lesions associated with complications of migraine, their nature and pathophysiology remain unclear.
  
  
  METHODS
  We report on a 38-year-old male who presented with nine episodes of SM and PA over eight years. Serial neuroimaging studies including brain magnetic resonance imaging (MRI), blood flow single photon emission tomography (SPECT),(18) F-fluorodeoxyglucose positron emission tomography (FDG-PET) and(11) C-flumazenil PET (FMZ-PET) demonstrated cerebral vasogenic edema (CVE) with hypoperfusion and hypometabolism in the area, anatomically corresponding to the area with PA. SM and PA were effectively controlled by corticosteroid therapy. Follow-up MRI revealed complete reversibility of the CVE, which was supported by normal FMZ-PET and FDG-PET findings.
  
  
  CONCLUSIONS
  We have described a patient with transient brain lesions associated with complications of migraine who was diagnosed with fully reversible and steroid responsive CVE.
authors.affiliation: Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Republic of Korea.
authors.forename: Yeon-Jung
authors.initials: YJ
authors.lastname: Kim
authors.affiliation: Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Republic of Korea sukwon@amc.seoul.kr.
authors.forename: Sun U
authors.initials: SU
authors.lastname: Kwon
mesh_terms: D000328:Adult; D001929:Brain Edema / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D020325:Migraine with Aura / Q000150:complications*; D018696:Neuroprotective Agents / Q000627:therapeutic use; D049268:Positron-Emission Tomography; D011239:Prednisolone / Q000627:therapeutic use; D012008:Recurrence; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D005938:Glucocorticoids; D018696:Neuroprotective Agents; D011239:Prednisolone; D008775:Methylprednisolone
keywords: Migraine; cerebral vasogenic edema